Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression

Journal of Psychiatric Research

Volumn 44, Issue 14, 2010, Pages 917-920

  Diniz, Breno Satler ^a   Teixeira, Antonio Lucio ^b   Talib, Leda Leme ^a   Mendonça, Vanessa Amaral ^b   Gattaz, Wagner Farid ^a   Forlenza, Orestes Vicente ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Early onset depression; Late life depression; Pathophysiology; Tumor necrosis factor ; Tumor necrosis factor soluble receptor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; MAJOR DEPRESSION; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; AGING; CASE-CONTROL STUDIES; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77957667487     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2010.02.008     Document Type: Article

References (29)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, Washington. 4th ed.
2. Andrei A.M., Fraguas R., Telles R.M., Alves T.C., Strunz C.M., Nussbacher A., et al. Major depressive disorder and inflammatory markers in elderly patients with heart failure. Psychosomatics 2007, 48:319-324.
3. Bremmer M.A., Beekman A.T., Deeg D.J., Penninx B.W., Dik M.G., Hack C.E., Hoogendijk W.J. Inflammatory markers in late-life depression: results from a population-based study. Journal of Affective Disorder 2008, 106:249-255.
4. Chadwick W., Magnus T., Martin B., Keselman A., Mattson M.P., Maudsley S. Targeting TNF-alpha receptors for neurotherapeutics. Trends in Neuroscience 2008, 31:504-511.
5. Coelho F.M., Narciso F.M., Oliveira D.M., Pereira D.S., Teixeira A.L., Teixeira M.M., Souza D.G., Pereira L.S. sTNFR-1 is an early inflammatory marker in community versus institutionalized elderly women. Inflammation Research 2009, Epub ahead of print. 10.1007/s00011-009-0079-6.
6. Dantzer R., Kelley K.W. Twenty years of research on cytokine-induced sickness behavior. Brain Behavior and Immunity 2007, 21:153-160.
7. Diniz Bs., Nunes P.V., Yassuda M.S., Pereira F.S., Flaks M.K., Viola L.F., et al. Mild cognitive impairment: cognitive screening or neuropsychological assessment?. Revista Brasileira de Psiquiatria 2008, 30:316-321. 10.1590/S1516-44462008000400003.
8. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for DSM-IV-TR Axis I disorders, research version, patient edition (SCID-I/P). Biometrics research 2002, New York State Psychiatric Institute, New York.
9. Folstein M.F., Folstein S.E., McHugh P.R. ''Mini-mental state''. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12:189-198.
10. Fotin-Mleczek M., Henkler F., Samel D., Reichwein M., Hausser A., Parmryd I., Scheurich P., Schmid J.A., Wajant H. Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8. Journal of Cell Science 2002, 115:2757-2770.
11. Franceschi C., Bonafè M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Annals of the New York Academy of Science 2000, 908:244-254.
12. Gerli R., Monti D., Bistoni O., Mazzone A.M., Peri G., Cossarizza A., Di Gioacchino M., Cesarotti M.E., Doni A., Mantovani A., Franceschi C., Paganelli R. Chemokines, sTNF-Rs and sCD30 serum levels in healthy aged people and centenarians. Mechanisms of Ageing and Development 2000, 121(1-3):37-46.
13. Grassi-Oliveira R., Brietzke E., Pezzi J.C., Lopes R.P., Teixeira A.L., Bauer M.E. Increased soluble tumor necrosis factor-alpha receptors in patients with major depressive disorder. Psychiatry and Clinical Neuroscience 2009, 63:202-208. 10.1111/j.1440-1819.2008.01918.x.
14. Hamilton M. A rating scale for depression. Journal of Neurology Neurosurgery and Psychiatry 1960, 23:56-62.
15. Hasegawa Y., Sawada M., Ozaki N., Inagaki T., Suzumura A. Increased soluble tumor necrosis factor receptor levels in the serum of elderly people. Gerontology 2000, 46:185-188.
16. Leonard B.E. Inflammation, depression and dementia: are they connected?. Neurochemical Research 2007, 32:1749-1756.
17. McCoy M.K., Tansey M.G. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. Journal of Neuroinflammation 2008, 5:45. 10.1186/1742-2094-5-45.
18. Micheau O., Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003, 114:181-190.
19. Nunes P.V., Diniz Bs., Radanovic M., Abreu I.D., Borelli D.T., Yassuda M.S., et al. CAMCOG as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education. International Journal of Geriatric Psychiatry 2008, 23:1127-1133. 10.1002/gps.2038.
20. Panagiotakos D.B., Pitsavos C., Chrysohoou C., Tsetsekou E., Papageorgiou C., Christodoulou G., Stefanadis C. ATTICA study. Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study. European Heart Journal 2004, 25(6):492-499.
21. Penninx B.W., Kritchevsky S.B., Yaffe K., Newman A.B., Simonsick E.M., Rubin S., et al. Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry 2003, 54:566-572.
22. Pereira L.S., Narciso F.M., Oliveira D.M., Coelho F.M., Souza Dda G., Dias R.C. Correlation between manual muscle strength and interleukin-6 (IL-6) plasma levels in elderly community-dwelling women. Archives of Gerontology and Geriatrics 2009, 48(3):313-316.
23. Roth M., Tim E., Mountjoy C.Q., Huppert F.A., Hendrie H., Verma S., et al. CAMDEX: a standardized instrument for the diagnosis of mental disorders in the elderly with special reference to early detection of dementia. British Journal of Psychiatry 1986, 149:698-709.
24. Scalzo P., Kümmer A., Cardoso F., Teixeira A.L. Increased serum levels of soluble tumor necrosis factor-alpha receptor-1 in patients with Parkinson's disease. Journal of Neuroimmunology 2009, Epub ahead of print. 10.1016/j.jneuroim.2009.08.001.
25. Soczynska J.K., Kennedy S.H., Goldstein B.I., Lachowski A., Woldeyohannes H.O., Mcintyre R.S. The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression?. Neurotoxicology 2009, 30:497-521.
26. Sunderland T., Hill J.L., Mellow A.M., Lawlor B.A., Gundersheimer J., Newhouse P.A., et al. Clock drawing in Alzheimer's disease. A novel measure of disease severity. Journal of the American Geriatric Society 1989, 37:725-729.
27. Thomas A.J., Davis S., Morris C., Jackson E., Harrison R., O'Brien J.T. Increase in interleukin-1beta in late-life depression. American Journal of Psychiatry 2005, 162(1):175-177.
28. van den Biggelaar A.H., Gussekloo J., de Craen A.J., Frölich M., Stek M.L., van der Mast R.C., Westendorp R.G. Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Experimental Gerontology 2007, 42(7):693-701.
29. Wajant H., Pfizenmaier K., Scheurich P. Tumor necrosis factor signaling. Cell Death Differentiation 2003, 10:45-65.